Mesoblast Limited Deal History & Licensing Activity
Mesoblast Limited is a life sciences. Over the past three years, Mesoblast Limited has been involved in 1 licensing and acquisition transaction, with a primary focus on CAR-T (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
CAR-T
Focus Area
Immunology
Mesoblast Limited Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Mesoblast Limited in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| CAR-MSC technology platform | Mayo Clinic | CAR-T | Preclinical | acquisition | Apr 2026 |
Mesoblast Limited Pipeline Focus
Therapeutic areas and modalities where Mesoblast Limited is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Mesoblast Limited's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Immunology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Immunology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for immunology
CAR-T Benchmarks
Upfront, milestone, and royalty benchmarks for car-t deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Mesoblast Limited Licensing & Deal Activity
Mesoblast Limited is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Mesoblast Limited ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Mesoblast Limited include Immunology (2 deals and trials). In terms of modality, Mesoblast Limited has shown particular interest in car-t.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Mesoblast Limited and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Mesoblast Limited's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.